Motor-axonal polyneuropathy associated with hepatitis C virus

Related Experiment Video

Updated: Sep 27, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

J Costa1, C Resende, M de Carvalho

  • 1Department of Neurology, Hospital de Santa Maria, Lisbon, Portugal.

European Journal of Neurology
|February 27, 2003
PubMed

Insights

Hepatitis C virus (HCV) infection is linked to nerve damage. This study identifies a new association between HCV and pure motor-axonal polyneuropathy, even without cryoglobulinemia.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Hepatology

Background:

  • Hepatitis C virus (HCV) infection is a known cause of mixed cryoglobulinemia and peripheral neuropathy.
  • Peripheral polyneuropathy has been associated with chronic HCV infection, often presenting as sensory axonopathies.
  • Cryoglobulinemia, particularly essential mixed cryoglobulinemia (type II), is frequently observed in HCV patients.

Observation:

  • Previous research documented sensory axonopathies or vasculitis with HCV-related neuropathy, especially when cryoglobulinemia is present.
  • The association between HCV and peripheral neuropathy without cryoglobulinemia has been noted.
  • This study observed a unique case of pure motor-axonal polyneuropathy in an HCV-infected patient without cryoglobulinemia.

Findings:

  • This is the first reported case of pure motor-axonal polyneuropathy associated with Hepatitis C virus infection in the absence of cryoglobulinemia.
  • The findings expand the spectrum of neurological manifestations linked to HCV.
  • This case highlights the need to consider HCV in patients with unexplained motor-axonal polyneuropathy, irrespective of cryoglobulinemia status.

Implications:

  • Clinicians should consider HCV testing in patients presenting with pure motor-axonal polyneuropathy, even without evidence of cryoglobulinemia.
  • This discovery may lead to earlier diagnosis and treatment of HCV-related neurological complications.
  • Further research is warranted to understand the pathogenesis of HCV-associated motor-axonal polyneuropathy.

More Related Videos

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...